Atossa Therapeutics (ATOS) vs Optimi Health (OPTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Atossa Therapeutics is the larger company by market cap ($24.1 million vs $23.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATOS | OPTH |
|---|---|---|
| Share price | $2.42 | $4.09 |
| Market cap | $24.15M | $23.39M |
| 1-day change | -1.63% | 0.00% |
| YTD return | -72.66% | — |
| 1-year return | -85.47% | — |
| 5-year return | -94.36% | — |
| EPS (TTM) | $-4.45 | $-1.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.00 | $6.40 |
| 52-week low | $1.70 | $4.00 |
| Distance from 52-week high | -86.56% | -36.17% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +685.12% | — |
| Average volume | 63.48K | 45.35K |
| Shares outstanding | 9.98M | 5.73M |
| Employees | 16 | — |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Atossa Therapeutics
ATOS stock →Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas.
Healthcare · Biotechnology · 16 employees
About Optimi Health
OPTH stock →Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
Healthcare · Drug Manufacturers - Specialty & Generic
ATOS vs OPTH FAQ
Which is bigger, Atossa Therapeutics or Optimi Health?
Atossa Therapeutics (ATOS) is larger, with a market capitalization of $24.15M compared with $23.39M for Optimi Health (OPTH).
Are Atossa Therapeutics and Optimi Health in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for Atossa Therapeutics and Drug Manufacturers - Specialty & Generic for Optimi Health.